Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis-Reference-Cited by-同舟云学术

Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis

Published:2022-01-25 Issue: Volume: Page:
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

McMahan Zsuzsanna H.¹^ORCID,Tucker Ana E.²^ORCID,Perin Jamie³,Volkmann Elizabeth R.⁴^ORCID,Kulkarni Subhash¹,Ziessman Harvey A.¹,Pasricha Pankaj J.¹,Wigley Fredrick M.¹

Affiliation:

1. Johns Hopkins University Baltimore Maryland

2. Johns Hopkins Bayview Medical Center Baltimore Maryland

3. Johns Hopkins Bloomberg School of Public Health Baltimore Maryland

4. University of California–Los Angeles

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Scleroderma Research Foundation

Publisher

Wiley

Subject

Rheumatology